Cargando…
Comparison of the clinical presentation across two waves of COVID-19: a retrospective cohort study
BACKGROUND: Only a few studies have performed comprehensive comparisons between hospitalized patients from different waves of COVID-19. Thus, we aimed to compare the clinical characteristics and laboratory data of patients admitted to the western part of Denmark during the first and second waves of...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063242/ https://www.ncbi.nlm.nih.gov/pubmed/35505306 http://dx.doi.org/10.1186/s12879-022-07413-3 |
_version_ | 1784699123322060800 |
---|---|
author | Buttenschøn, Henriette Nørmølle Lynggaard, Vibeke Sandbøl, Susanne Gundersborg Glassou, Eva Natalia Haagerup, Annette |
author_facet | Buttenschøn, Henriette Nørmølle Lynggaard, Vibeke Sandbøl, Susanne Gundersborg Glassou, Eva Natalia Haagerup, Annette |
author_sort | Buttenschøn, Henriette Nørmølle |
collection | PubMed |
description | BACKGROUND: Only a few studies have performed comprehensive comparisons between hospitalized patients from different waves of COVID-19. Thus, we aimed to compare the clinical characteristics and laboratory data of patients admitted to the western part of Denmark during the first and second waves of COVID-19 in 2020. Furthermore, we aimed to identify risk factors for critical COVID-19 disease and to describe the available information on the sources of infection. METHODS: We performed a retrospective study of medical records from 311 consecutive hospitalized patients, 157 patients from wave 1 and 154 patients from wave 2. The period from March 7 to June 30, 2020, was considered wave 1, and the period from July 1st to December 31, 2020, was considered wave 2. Data are presented as the total study population, as a comparison between waves 1 and 2, and as a comparison between patients with and without critical COVID-19 disease (nonsurvivors and patients admitted to the intensive care unit (ICU)). RESULTS: Patients admitted during the first COVID-19 wave experienced a more severe course of disease than patients admitted during wave 2. Admissions to the ICU and fatal disease were significantly higher among patients admitted during wave 1 compared to wave 2. The percentage of patients infected at hospital decreased in wave 2 compared to wave 1, whereas more patients were infected at home during wave 2. We found no significant differences in sociodemographics, lifestyle information, or laboratory data in the comparison of patients from waves 1 and 2. However, age, sex, smoking status, comorbidities, fever, and dyspnea were identified as risk factors for critical COVID-19 disease. Furthermore, we observed significantly increased levels of C-reactive protein and creatinine, and lower hemoglobin levels among patients with critical disease. CONCLUSIONS: At admission, patients were more severely ill during wave 1 than during wave 2, and the outcomes were worse during wave 1. We confirmed previously identified risk factors for critical COVID-19 disease. In addition, we found that most COVID-19 infections were acquired at home. |
format | Online Article Text |
id | pubmed-9063242 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-90632422022-05-03 Comparison of the clinical presentation across two waves of COVID-19: a retrospective cohort study Buttenschøn, Henriette Nørmølle Lynggaard, Vibeke Sandbøl, Susanne Gundersborg Glassou, Eva Natalia Haagerup, Annette BMC Infect Dis Research BACKGROUND: Only a few studies have performed comprehensive comparisons between hospitalized patients from different waves of COVID-19. Thus, we aimed to compare the clinical characteristics and laboratory data of patients admitted to the western part of Denmark during the first and second waves of COVID-19 in 2020. Furthermore, we aimed to identify risk factors for critical COVID-19 disease and to describe the available information on the sources of infection. METHODS: We performed a retrospective study of medical records from 311 consecutive hospitalized patients, 157 patients from wave 1 and 154 patients from wave 2. The period from March 7 to June 30, 2020, was considered wave 1, and the period from July 1st to December 31, 2020, was considered wave 2. Data are presented as the total study population, as a comparison between waves 1 and 2, and as a comparison between patients with and without critical COVID-19 disease (nonsurvivors and patients admitted to the intensive care unit (ICU)). RESULTS: Patients admitted during the first COVID-19 wave experienced a more severe course of disease than patients admitted during wave 2. Admissions to the ICU and fatal disease were significantly higher among patients admitted during wave 1 compared to wave 2. The percentage of patients infected at hospital decreased in wave 2 compared to wave 1, whereas more patients were infected at home during wave 2. We found no significant differences in sociodemographics, lifestyle information, or laboratory data in the comparison of patients from waves 1 and 2. However, age, sex, smoking status, comorbidities, fever, and dyspnea were identified as risk factors for critical COVID-19 disease. Furthermore, we observed significantly increased levels of C-reactive protein and creatinine, and lower hemoglobin levels among patients with critical disease. CONCLUSIONS: At admission, patients were more severely ill during wave 1 than during wave 2, and the outcomes were worse during wave 1. We confirmed previously identified risk factors for critical COVID-19 disease. In addition, we found that most COVID-19 infections were acquired at home. BioMed Central 2022-05-03 /pmc/articles/PMC9063242/ /pubmed/35505306 http://dx.doi.org/10.1186/s12879-022-07413-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Buttenschøn, Henriette Nørmølle Lynggaard, Vibeke Sandbøl, Susanne Gundersborg Glassou, Eva Natalia Haagerup, Annette Comparison of the clinical presentation across two waves of COVID-19: a retrospective cohort study |
title | Comparison of the clinical presentation across two waves of COVID-19: a retrospective cohort study |
title_full | Comparison of the clinical presentation across two waves of COVID-19: a retrospective cohort study |
title_fullStr | Comparison of the clinical presentation across two waves of COVID-19: a retrospective cohort study |
title_full_unstemmed | Comparison of the clinical presentation across two waves of COVID-19: a retrospective cohort study |
title_short | Comparison of the clinical presentation across two waves of COVID-19: a retrospective cohort study |
title_sort | comparison of the clinical presentation across two waves of covid-19: a retrospective cohort study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063242/ https://www.ncbi.nlm.nih.gov/pubmed/35505306 http://dx.doi.org/10.1186/s12879-022-07413-3 |
work_keys_str_mv | AT buttenschønhenriettenørmølle comparisonoftheclinicalpresentationacrosstwowavesofcovid19aretrospectivecohortstudy AT lynggaardvibeke comparisonoftheclinicalpresentationacrosstwowavesofcovid19aretrospectivecohortstudy AT sandbølsusannegundersborg comparisonoftheclinicalpresentationacrosstwowavesofcovid19aretrospectivecohortstudy AT glassouevanatalia comparisonoftheclinicalpresentationacrosstwowavesofcovid19aretrospectivecohortstudy AT haagerupannette comparisonoftheclinicalpresentationacrosstwowavesofcovid19aretrospectivecohortstudy |